KELLEN ROLLING: Open Payments
NPI 1821310095 · HOOVER, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 116 payments from 15 companies in 2025. Trend: 2023 $2,349 · 2024 $1,628 · 2025 $1,543
Food & beverage: $1,543
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $357 |
| ABBVIE INC. | 31 | $350 |
| Amgen Inc. | 16 | $182 |
| Lilly USA, LLC | 11 | $162 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| PFIZER INC. | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Corcept Therapeutics | 3 | $56 |
| SHIELD THERAPEUTICS INC | 3 | $51 |
| Exact Sciences Corporation | 3 | $47 |
Products named: Wegovy, UBRELVY, MOUNJARO, VRAYLAR, Rybelsus, OTEZLA, TRINTELLIX, QULIPTA.
Industry payments across AL — which companies pay providers there.
